Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 1,900 shares, a decrease of 98.2% from the March 31st total of 106,700 shares. Based on an average daily trading volume, of 41,900 shares, the days-to-cover ratio is presently 0.0 days.
Analysts Set New Price Targets
Separately, Raymond James started coverage on Sernova in a research note on Thursday, April 4th. They issued a “market perform” rating and a $1.50 price objective for the company.
Read Our Latest Stock Report on Sernova
Sernova Trading Up 2.9 %
Sernova (OTCMKTS:SEOVF – Get Free Report) last announced its earnings results on Monday, March 18th. The company reported ($0.02) EPS for the quarter.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Articles
- Five stocks we like better than Sernova
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Quiet Period Expirations Explained
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Comparing and Trading High PE Ratio Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.